Concepedia

Publication | Open Access

CHIR-258: A Potent Inhibitor of FLT3 Kinase in Experimental Tumor Xenograft Models of Human Acute Myelogenous Leukemia

DOIFull Paper Access

111

Citations

33

References

2005

Year

Daniel E. Lopes de Menezes, Jing Peng, Evelyn N. Garrett, Sharianne G. Louie, Sang H. Lee, Marion Wiesmann, Yan Tang, L.B. Shephard, Cheryl Goldbeck, Yoko Oei,
Clinical Cancer Research

Abstract

Our data indicate that CHIR-258 may be an effective therapy in FLT3-associated AML and warrants clinical trials.

References

YearCitations

Page 1